Florence Van Obbergh

Jolimont, WAL, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

Blinatumomab consolidation for high-risk Ph- B-cell acute lymphoblastic leukemia: the GRAALL-2014/B-QUEST study.

Journal: Blood

Published: January 20, 2026

Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study.

Blinatumomab Consolidation for High-Risk Ph-negative B-cell Acute Lymphoblastic Leukemia: the GRAALL-2014/B-QUEST Study.

Journal: Blood

Published: January 20, 2026

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Addition of the nuclear export inhibitor selinexor to standard intensive treatment for elderly patients with acute myeloid leukemia and high risk myelodysplastic syndrome.

Journal: Leukemia

Published: May 24, 2022

COVID-19, impact on myeloma patients.

COVID-19, impact on myeloma patients.

Journal: Annals of hematology

Published: May 08, 2020

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.

Journal: Acta clinica Belgica

Published: May 05, 2020

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.

Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres.

Journal: Bone marrow transplantation

Published: August 03, 2018

The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study.

The clinical relevance of imatinib plasma trough concentrations in chronic myeloid leukemia. A Belgian study.

Journal: Clinical biochemistry

Published: August 31, 2016

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.

Analysis of phenotype and outcome in essential thrombocythemia with CALR or JAK2 mutations.

Journal: Haematologica

Published: October 01, 2014

Clonal chromosomal abnormalities in Ph-negative cells in chronic myeloid leukemia: an unusual case evolving to secondary acute myeloid leukemia.

Clonal chromosomal abnormalities in Ph-negative cells in chronic myeloid leukemia: an unusual case evolving to secondary acute myeloid leukemia.

Journal: Cancer genetics

Published: August 22, 2014

A case with a cytogenetically cryptic variant of the inv(16)(p13q22)/t(16;16)(p13;q22).

A case with a cytogenetically cryptic variant of the inv(16)(p13q22)/t(16;16)(p13;q22).

Journal: Cancer genetics

Published: March 19, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026